General
Venus Remedies Secures Ukrainian GMP Renewal: A Strategic Leap for Investors Eyeing Global Pharma Growth. Why This Certification Positions Venus Remedies as a Stock to Watch
Introduction: A Certification That Signals Growth In a significant stride toward fortifying its global pharmaceutical footprint, Venus Remedies Limited (NSE: VENUSREM, BSE: 526953) announced the
Read More